151 related articles for article (PubMed ID: 37723516)
1. Medico-economic impact of thoracoscopy versus thoracotomy in lung cancer: multicentre randomised controlled trial (Lungsco01).
Soilly AL; Aho Glélé LS; Bernard A; Abou Hanna H; Filaire M; Magdaleinat P; Marty-Ané C; Tronc F; Grima R; Baste JM; Thomas PA; Richard De Latour B; Pforr A; Pagès PB
BMC Health Serv Res; 2023 Sep; 23(1):1004. PubMed ID: 37723516
[TBL] [Abstract][Full Text] [Related]
2. Medicoeconomic analysis of lobectomy using thoracoscopy versus thoracotomy for lung cancer: a study protocol for a multicentre randomised controlled trial (Lungsco01).
Pagès PB; Abou Hanna H; Bertaux AC; Serge Aho LS; Magdaleinat P; Baste JM; Filaire M; de Latour R; Assouad J; Tronc F; Jayle C; Mouroux J; Thomas PA; Falcoz PE; Marty-Ané CH; Bernard A
BMJ Open; 2017 Jun; 7(6):e012963. PubMed ID: 28619764
[TBL] [Abstract][Full Text] [Related]
3. Impact of video-assisted thoracoscopic lobectomy versus open lobectomy for lung cancer on recovery assessed using self-reported physical function: VIOLET RCT.
Lim E; Harris RA; McKeon HE; Batchelor TJ; Dunning J; Shackcloth M; Anikin V; Naidu B; Belcher E; Loubani M; Zamvar V; Dabner L; Brush T; Stokes EA; Wordsworth S; Paramasivan S; Realpe A; Elliott D; Blazeby J; Rogers CA
Health Technol Assess; 2022 Dec; 26(48):1-162. PubMed ID: 36524582
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness evaluation of robotic-assisted thoracoscopic surgery versus open thoracotomy and video-assisted thoracoscopic surgery for operable non-small cell lung cancer.
Chen D; Kang P; Tao S; Li Q; Wang R; Tan Q
Lung Cancer; 2021 Mar; 153():99-107. PubMed ID: 33482409
[TBL] [Abstract][Full Text] [Related]
5. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of guideline-based stepped and collaborative care versus treatment as usual for patients with depression - a cluster-randomized trial.
Brettschneider C; Heddaeus D; Steinmann M; Härter M; Watzke B; König HH
BMC Psychiatry; 2020 Aug; 20(1):427. PubMed ID: 32859177
[TBL] [Abstract][Full Text] [Related]
8. Lobectomy for early-stage lung carcinoma: a cost analysis of full thoracoscopy versus posterolateral thoracotomy.
Ramos R; Masuet C; Gossot D
Surg Endosc; 2012 Feb; 26(2):431-7. PubMed ID: 21898011
[TBL] [Abstract][Full Text] [Related]
9. Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT.
Bhatnagar R; Luengo-Fernandez R; Kahan BC; Rahman NM; Miller RF; Maskell NA
Health Technol Assess; 2020 Jun; 24(26):1-90. PubMed ID: 32525474
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness Analysis of Robotic-assisted Lobectomy for Non-Small Cell Lung Cancer.
Heiden BT; Mitchell JD; Rome E; Puri V; Meyers BF; Chang SH; Kozower BD
Ann Thorac Surg; 2022 Jul; 114(1):265-272. PubMed ID: 34389311
[TBL] [Abstract][Full Text] [Related]
11. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
[TBL] [Abstract][Full Text] [Related]
12. Primary trabeculectomy versus primary glaucoma eye drops for newly diagnosed advanced glaucoma: TAGS RCT.
King AJ; Fernie G; Hudson J; Kernohan A; Azuara-Blanco A; Burr J; Homer T; Shabaninejad H; Sparrow JM; Garway-Heath D; Barton K; Norrie J; McDonald A; Vale L; MacLennan G
Health Technol Assess; 2021 Nov; 25(72):1-158. PubMed ID: 34854808
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States.
Shah BD; Smith NJ; Feng C; Jeyakumar S; Castaigne JG; Faghmous I; Masouleh BK; Malone DC; Bishop MR
Adv Ther; 2022 Aug; 39(8):3678-3695. PubMed ID: 35727476
[TBL] [Abstract][Full Text] [Related]
14. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
15. Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer.
Stenehjem DD; Bellows BK; Yager KM; Jones J; Kaldate R; Siebert U; Brixner DI
Oncologist; 2016 Feb; 21(2):196-204. PubMed ID: 26614710
[TBL] [Abstract][Full Text] [Related]
16. Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial.
Bendixen M; Jørgensen OD; Kronborg C; Andersen C; Licht PB
Lancet Oncol; 2016 Jun; 17(6):836-844. PubMed ID: 27160473
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non-small Cell Lung Cancer in the Italian National Health Service.
Armeni P; Borsoi L; Fornaro G; Jommi C; Grossi F; Costa F
Clin Ther; 2020 May; 42(5):830-847. PubMed ID: 32354495
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service.
Armeni P; Borsoi L; Fornaro G; Jommi C; Colombo N; Costa F
Clin Ther; 2020 Jul; 42(7):1192-1209.e12. PubMed ID: 32591103
[TBL] [Abstract][Full Text] [Related]
19. Cost-utility analysis of minimally invasive surgery for lung cancer: a randomized controlled trial.
Bendixen M; Kronborg C; Jørgensen OD; Andersen C; Licht PB
Eur J Cardiothorac Surg; 2019 Oct; 56(4):754-761. PubMed ID: 30838382
[TBL] [Abstract][Full Text] [Related]
20. Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation.
Clarke A; Pulikottil-Jacob R; Grove A; Freeman K; Mistry H; Tsertsvadze A; Connock M; Court R; Kandala NB; Costa M; Suri G; Metcalfe D; Crowther M; Morrow S; Johnson S; Sutcliffe P
Health Technol Assess; 2015 Jan; 19(10):1-668, vii-viii. PubMed ID: 25634033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
